ArticleClinical and experimental medicine2026
Pan-cancer analysis identifies KANSL2 as a cell-cycle-associated regulator of tumor progression and immunity in liver hepatocellular carcinoma.
Nanbin Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.